MREM Press Releases
PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth services
RALEIGH, N.C. and BALTIMORE, April 14 (Bernama-GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) and the Maryland State Medical Society (MedChi) announced today that Care Innovations, a PRA Health Sciences company, was selected by MedChi to be a preferred provider of remote patient monitoring, telehealth, and digital health services for
Green Tiger Markets Partners With SSY Futures Ltd
SINGAPORE, April 14 (Bernama-BUSINESS WIRE) — Green Tiger Markets Pte Ltd. (GTM) today announced its partnership with SSY Futures Ltd to act as the exclusive broker to its leading-edge, over-the-counter electricity marketplace for Philippines and Singapore electricity forwards. Green Tiger Markets is delighted to be working with SSY Futures Ltd, the leading
PRINCETON DIGITAL GROUP Secures $230 Million Financing, Charts Out $1 Billion Expansion in China
SINGAPORE & SHANGHAI, April 14 (Bernama-BUSINESS WIRE) — Singapore-based Princeton Digital Group (PDG), Asia’s leading data center provider, today announced it has secured USD 230 million debt refinancing from China Merchants Bank, as part of its USD 1 billion expansion plan in China. The refinancing validates PDG’s momentum, with confirmation of the completion
Smiths Detection Announces University Of Maryland, Baltimore County Successfully Deploys BioFlash For Airborne Detection Of SARS-CoV-2
University’s ESH Team Deploys Portable Detector on Campus to Protect Students, Faculty and Staff from Virus Exposure LONDON, April 14 (Bernama-BUSINESS WIRE) — Smiths Detection, a global leader in threat detection and security screening technologies, today announces that its BioFlash® Biological Identifier has been successfully used by the University of Maryland, Baltimore County
Smiths Detection confirms BioFlash capable of airborne COVID-19 detection
LONDON, April 14 (Bernama-BUSINESS WIRE) — Smiths Detection, a global leader in threat detection and security screening technologies, confirms its BioFlash® Biological Identifier is capable of detecting airborne COVID-19 following tests conducted by the University of Oregon, positioning the technology as an effective environmental monitoring tool for use in indoor public spaces. The
MIDF Inks MOU With MIDA On Smart Automation Grant To Drive Malaysian Companies Into Automation
KUALA LUMPUR, April 14 (Bernama) — The Malaysian Industrial Development Finance Berhad (MIDF) has inked a Memorandum of Understanding (MOU) with the Malaysian Investment Development Authority (MIDA) to offer small and medium enterprises (SMEs) and Mid-Tier Companies (MTCs) the opportunity to benefit from MIDA’s Smart Automation Grant (SAG). The SAG initiative,
Agthia Embarks on Transformational Journey with its Strategy to Become an F&B Leader by 2025
ABU DHABI, United Arab Emirates, April 14 (Bernama-BUSINESS WIRE) — Agthia Group PJSC revealed its long-term strategy to become an F&B leader in the Middle East, North Africa and Pakistan (MENAP) region and beyond by 2025. The strategy is built on three strategic pillars (growth, efficiency and capability) and is
RubrYc Therapeutics Announces A Research Collaboration And License Option Agreement With Zai Labs
SAN CARLOS, Calif., April 14 (Bernama-BUSINESS WIRE) — RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies
Global Employee Relocations Served by WHR’s International Offices
MILWAUKEE, Wis., April 14 (Bernama-GLOBE NEWSWIRE) — During 2020, WHR Group, Inc. (WHR) opened international offices in Singapore, and Basel, Switzerland, to support its global employee relocation services. These offices provide a range of services including pre-assignment, transition, on assignment and repatriation services to multi-language expatriate transferees. Along with its
LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer
GUANGZHOU, China, April 14 (Bernama-BUSINESS WIRE) — LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that China’s health authority, National Medical Products Administration (NMPA) authorized the company to proceed with a Phase 1/2 clinical trial